Gangwon-do, South Korea

Min-Soo Kim


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2019-2021

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Min-Soo Kim: Innovator in Diabetic Complications Treatment

Introduction

Min-Soo Kim is a prominent inventor based in Gangwon-do, South Korea. He has made significant contributions to the field of medical science, particularly in the prevention and treatment of diabetic complications. With a total of two patents to his name, his work focuses on innovative solutions to combat the challenges posed by diabetes.

Latest Patents

Min-Soo Kim's latest patents include a method for the prevention or treatment of diabetic complications. This invention discloses a composition that contains a benzodiazepine-based compound. The composition is designed to effectively prevent or treat diseases resulting from hyperglycemia, which is a leading cause of diabetes. Specifically, it addresses diseases caused by vascular leakage, providing a promising avenue for diabetic patients.

Career Highlights

Min-Soo Kim is affiliated with the Kangwon National University University-Industry Cooperation Foundation. His role at this institution allows him to engage in research and development that bridges the gap between academia and industry. His innovative work has garnered attention in the medical community, highlighting his commitment to improving patient outcomes.

Collaborations

Some of Min-Soo Kim's notable coworkers include Kwon-Soo Ha and Yeon-Ju Lee. Their collaborative efforts contribute to the advancement of research in diabetic complications and enhance the impact of their findings.

Conclusion

Min-Soo Kim stands out as an influential inventor in the realm of diabetic treatment. His innovative patents and collaborative work reflect his dedication to addressing critical health issues. Through his contributions, he continues to pave the way for advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…